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Abstract
BACKGROUND: The cytokine gene polymorphism is associated with the development of metabolic disorder 
conditions and infectious diseases such as Type 2 diabetes mellitus (T2DM) and tuberculosis (TB) disease.
AIM: The objective of the study is an attempt to examine the association of cytokine genes polymorphisms 
(IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) in T2DM-TB patients.
METHODS: The cytokine genes polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) were investigated 
in 46 T2DM-TB patients, 46 T2DM patients, and 46 healthy controls. Cytokine genes polymorphism was carried out 
by the polymerase chain reaction-restriction fragment length polymorphism. Odds ratio (OR) with 95% confidence 
interval (CI) and p-value was calculated to determine the association between cytokine genes polymorphisms as the 
risk factor to T2DM-TB development.
RESULTS: No association between genotypes and alleles of cytokine genes polymorphisms (IL1β+3954 C/T, IL18-
137 G/C, and IL18-607 C/A) in T2DM-TB compared to control group (p = 0.434; OR = 0.373; 95% CI = 0.068-2.028 
and p = 0.444; OR = 0.387; 95% CI = 0.073–2.046), (p = 0.833; OR = 0.915; 95% CI = 0.400–2.092 and p = 0.864; 
OR = 1.061; 95% CI = 0.541–2.078), and (p = 0.815; OR = 0.896; 95% CI = 0.357–2.246 and p = 0.882; OR = 0.957; 
95% CI = 0.534–1.715). This study also found no association between genotypes and alleles of cytokine genes 
polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) with T2DM-TB compared to T2DM group (p = 1; 
OR = 0.652; 95% CI = 0.104–4.094 and p = 1; OR = 0.659; 95% CI = 0.108–4.041), (p = 0.189; OR = 1.786; 95% 
CI = 0.749–4.262 and p = 0.098; OR = 1.857; 95% CI = 0.887–3.889), and (p = 0.374; OR = 1.488; 95% CI = 0619–
3.579 and p = 0.365; OR = 1.316; 95% CI=0.727–2.382).
CONCLUSION: There is no association of the cytokine genes polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and 
IL18-607 C/A) in T2DM-TB compared to control and T2DM groups, and all cytokine genes polymorphisms not as the 
risk factor to T2DM-TB development in this population.
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Introduction
Type 2 diabetes mellitus (T2DM) is a 
metabolic disorder that has implications for the 
increased risk of tuberculosis (TB). Since the 
beginning of the 20th century, clinicians have observed 
an association between T2DM and TB [1]. T2DM 
was found in around 2–9% of the population in 22 
countries with the highest burden of TB. Eight of ten 
countries with the highest incidence of T2DM in the 
world are also classified as the highest pulmonary TB 
burden [2]. T2DM patients have 2–3 times the risk 
of developing TB than people without T2DM. People 
with low immune systems due to chronic diseases 
such as T2DM have a higher risk of developing 
latent TB to active TB. The innate immune system is 
compromised by high blood glucose levels (BGLs), 
which increases the risk of developing infectious 
diseases such as TB [3], [4].
Increased BGLs in T2DM are associated with 
an inflammatory state characterized by cytokines such 
as interleukin (IL)-1, IL-6, IL-18, and tumor necrosis 
factor-α (TNF-α). Cytokines genes polymorphisms are 
thought to be one of the genetic factors involved in the 
pathogenesis of T2DM development. Previous studies 
have shown that polymorphism of IL18-607 C/A gene was 
associated with 2 h post-loading plasma glucose level in 
T2DM. Another previous study in the Chinese population 
showed that IL18-137 G/C gene polymorphism had a 
risk of T2DM with nephropathy. IL-18 was identified as 
an interferon (INF)-gamma inducing factor. IL-18 gene 
is located at 11q22.2-22.3, including six exons and five 
introns. IL18-607 C/A and IL18-137 G/C polymorphism 
are located at the promoter region of exon 1 in IL-18 
gene [5], [6], [7]. Based on other studies, there is result 
showing that the IL-18 gene polymorphism also plays a 
role in the development mechanism of TB. A study by 
Han et al. (2010) showed an association between IL18-
607 C/A gene polymorphism with TB [8].
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The other cytokine gene polymorphism, that 
is, IL1β+3954 C/T is known to be associated with the 
development of TB in the Colombia population. The 
IL-1β gene is located on chromosome 2q13–q21. 
Single nucleotide polymorphisms (SNPs) in the IL1β 
promoter have been reported, some of which may 
regulate IL-1β expression. Allele T of the +3953 SNP, 
located at exon 5, was associated with a decrease in 
IL-1β production under inflammatory circumstances. 
ProIL1β is biologically inactive and must be converted 
to 17 kDa IL1β to function. IL1β is processed and 
released from cells by a mechanism involving caspase 
1 [9], [10], [11].
The study regarding the association of the IL-18 
gene and T2DM-TB showed that an association between 
IL18-607 C/A gene polymorphism with T2DM-TB but 
no showed an association between 137 G/C gene 
polymorphism [12]. To the best of our knowledge, no 
studies have yet reported the association of IL1β+3954 
C/T with T2DM-TB. In this study, we analysis the 
association of the cytokine genes polymorphisms 
(IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) in 
T2DM-TB patients, T2DM patients, and healthy control 
groups at Medan city population, Indonesia.
Materials and Methods
Ethical agreement
Informed consent was given to each subject 
after receiving a simple description of the purposes 
and benefits of the study. The protocol of this study has 
been approved by the ethics committee of the Faculty of 
Medicine, Universitas Sumatera Utara (USU) (KEPK-FK 
USU-RSUP HAM No. 227/2018 and 447/2019) following 
the Second Declaration of Helsinki. The study was 
conducted from March 2018 to June 2019.
Study design and subjects
A case-control design was conducted on 
subjects in several places. T2DM-TB subjects were 
recruited from health-care facilities for pulmonary 
disease in Medan city, T2DM patients were recruited 
from USU Hospital Medan, and the healthy control 
were employees of USU medical faculty in Medan, 
Indonesia. A total of 138 subjects consisting of 46 
T2DM-TB patients, 46 T2DM patients, and 46 healthy 
controls. The diagnosis of T2DM-TB and T2DM 
patients was based on the Indonesian Lung Doctor 
Association [13] and Indonesian Endocrinology 
Society [14]. Characteristics of subjects in this study, 
including age, gender, family history of T2DM, and 
smoking habit, were collected through interviews using 
questionnaires.
Blood samples, BGLs examination, and 
DNA extraction
Blood samples (5 ml) were collected in plain 
and ethylenediaminetetraacetic acid tubes from the 
median cubital vein under aseptic conditions. The 
BGLs were tested in the USU hospital according to the 
routine procedure in the hospital. The criteria for BGLs 
of healthy control were <126 mg/dl.
The analysis of cytokine genes polymorphisms 
started from the DNA extraction from each subject’s 
blood samples at Biomolecular Laboratory, Medical 
Faculty of USU. A total of 200 µL of blood from 138 
patients were isolated using the Promega extraction 
kit (USA). The DNA isolation procedure was carried 
out according to the manual kit. The isolated DNA 
stored at −80°C for further analysis. The quality 
and quantity of the DNA samples were evaluated 
by agarose gel electrophoresis and ultraviolet (UV) 
spectrophotometer Nanodrop with an absorbance of 
260/280 and 260/230.
Genotyping
Genotyping of cytokines was obtained using 
the polymerase chain reaction (PCR) technique. PCR 
solution of IL1β+3954 C/T gene consists of 23 µL 
(12.5 µL Go Taq master mix from Promega, USA, each 
1 µL reverse primer and forward primer 8.5 µL nuclease-
free water), and then 2 µL of isolated DNA was added. 
The PCR products for IL1β+3954 C/T gene were further 
analysis by the restriction fragment length polymorphism 
(RFLP) and digested with restriction enzymes.
PCR solution of IL18-137 G/C and IL18-607 C/A 
genes consisted of F1 solution and F2 solution. The F1/
F2 solution was made with a volume of 23 µL (12.5 µL 
Go Taq master mix, each 1 µL reverse primer, F1/F2 
primer, and control primer, 7.5 µL nuclease-free water), 
and 2 µL of isolated DNA was added. PCR primers, PCR 
conditions, and restriction enzymes for each gene were 
shown in Table 1, as described previously [15], [16].
PCR and RFLP products were analysis using 
agarose gel (UltraPureTM) electrophoresis technique of 
2% (PCR) or 4% (RFLP) at 100 volts in 1 h. Then, the 
electrophoresis results were visualized using Gel Doc 
1000 (Bio-Rad, USA) with UV light and the fragment of 
each gene was shown in Table 2.
Statistical analysis
All of the statistical analyses were performed 
with SPSS version 24. The distribution of genotypes 
and alleles of cytokine genes frequency was calculated 
by direct counting. Hardy-Weinberg equilibrium (HWE) 
from cytokine genes in all groups studied was calculated 
using Chi-square goodness-of-fit test. The association 
between cytokine genes polymorphisms as a risk factor 
to T2DM-TB was assessed using the Chi-square test 
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or Fisher’s exact test with an odds ratio (OR) and 
confidence interval (CI) 95%.
Table 2: DNA fragments of cytokine genes
Polymorphism PCR amplicon Homozygous 
wild-type
Homozygous 
mutant
Heterozygous
IL1β+3954 C/T 249 bp CC 135+114 
bp
TT 249 bp CT 
249+135+114 bp
IL 18-137 G/C 261 bp Control: 
446 bp
GG F1: 
261+446 bp 
F2: 446 bp
CC F1: 
446 bp F2: 
261+446 bp
GC F1:261+446 bp 
F2:261+446 bp
IL 18-607 C/A 196 bp Control: 
301 bp
CC F1: 
196+301 bp 
F2: 301 bp
AA F1: 301bp 
F2: 196+301 
bp
CA F1:196+301 bp 
F2:196+301 bp
PCR: Polymerase chain reaction.
Results
In this study, the clinical and laboratorial 
characteristics of T2DM-TB patients, T2DM patients, 
and controls are summarized in Table 3.
Table 3: The clinical and laboratorial characteristics of T2DM-TB 
patients, T2DM patients, and controls
Characteristic Control T2DM T2DM-TB
Age (years), (mean ± SD) 42.52 ± 13.15 55.95 ± 12.11 53.50 ± 8.27
Gender (n; %)
Male 25 (54.3) 25 (54.3) 32 (69.6)
Female 21 (45.7) 21 (45.7) 14 (30.4)
Family history of T2DM
No 37 (80.4) 15 (32.6) 37 (80.4)
Yes 9 (19.6) 31 (67.4) 9 (19.6)
BGLs (mg/dl) (mean ± SD) 118.98 ± 28.75 301.11 ± 100.35 304.33 ± 68.77
Cigarette smoking (n; %)
Never 37 (80.5) 28 (60.9) 19 (41.3)
Former 3 (6.5) 12 (26.1) 20 (43.5)
Current smoker 6 (13.0) 6 (13.0) 7 (15.2)
T2DM: Type 2 diabetes mellitus, TB: Tuberculosis, BGL: Blood glucose level.
The distribution of genotype and allele of 
cytokines and analysis of HWE in the population studied 
are summarized in Table 4.
The IL1β+3954 C/T gene, wild type CC 
genotypes was found the most in the T2DM-TB group 
(controls vs. T2DM vs. T2DM-TB = 89.1% vs. 93.5% 
vs. 95.7%), while CT genotype was found the most in 
the control group (controls vs. T2DM vs. T2DM-TB = 
10.9% vs. 6.5% vs. 4.3%). There is no TT genotype 
of IL1+3954 C/T in this population studied. C allele of 
IL1β+3954 C/T gene was found the most in T2DM-TB 
group than the other groups, while T allele of IL1β+3954 
C/T gene was found the most in the control group than 
the others groups.
Table 4: Distribution of genotype and allele of cytokines and 
analysis of Hardy-Weinberg equilibrium in the population studied
Cytokine genes Control n (%) T2DM n (%) T2DM-TB n (%)
IL1β+3954 C/T
Homozygote wild type/CC 41 (89.1) 43 (93.5) 44 (95.7)
Heterozygote mutant/CT 5 (10.9) 3 (6.5) 2 (4.3)
Homozygote mutant/TT 0 (0) 0 (0) 0 (0)
C allele 87 (94.6) 89 (96.7) 90 (97.8)
T allele 5 (5.4) 3 (3.3) 2 (2.2)
HWE; X2 (p-value) 0.151 (0.696) 0.052 (0.819) 0.022 (0.880)
IL 18-137 G/C
Homozygote wild type/GG 26 (56.5) 33 (71.7) 27 (58.7)
Heterozygote mutant/GC 18 (39.2) 12 (26.1) 15 (32.6)
Homozygote mutant/CC 2 (4.3) 1 (2.2) 4 (8.7)
G allele 70 (76.1) 78 (84.8) 69 (75.0)
C allele 22 (23.9) 14 (15.2) 23 (25.0)
HWE; X2 (p-value) 0.260 (0.609) 0.005 (0.940) 0.782 (0.376)
IL 18-607 C/A
Homozygote wild type/CC 12 (26.1) 17 (37.0) 13 (28.3)
Heterozygote mutant/CA 28 (60.9) 25 (54.3) 27 (58.7)
Homozygote mutant/AA 6 (13.0) 4 (8.7) 6 (13.0)
C allele 52 (56.5) 59 (64.1) 53 (57.6)
A allele 40 (43.5) 33 (35.9) 39 (42.4)
HWE; X2 (p-value) 2.615 (0.105) 1.512 (0.218) 1.872 (0.171)
T2DM: Type 2 diabetes mellitus, TB: Tuberculosis, HWE: Hardy-Weinberg equilibrium.
On the other hand, in the IL18-137 G/C gene, 
wild type GG genotype was found the most in the 
T2DM group (control vs. T2DM vs. T2DM-TB = 56.5% 
vs. 71.7% vs. 58.7%), whereas GC was found the most 
in the control group (control vs. T2DM vs. T2DM-TB = 
39.2% vs. 26.1% vs. 32.6%) and CC genotypes were 
found the most in the T2DM-TB group (control vs. 
T2DM vs. T2DM-TB = 4.3% vs. 2.2% vs. 8.7%). G allele 
of the IL18-137 G/C gene was found the most in T2DM 
group than the other groups, while C allele of IL18-137 
G/C gene was found the most in T2DM-TB group than 
the others groups.
Table 5: Cytokine genes polymorphisms and the risk of 
T2DM-TB in the population studied
Cytokine genes T2DM-TB vs. control T2DM-TB vs. T2DM
p-value OR (95% CI) p-value OR (95% CI)
IL1β+3954 C/T
CC - 1 (reference) - 1 (reference)
CT+TT 0.434 0.373 (0.068–2.028) 1 0.652 (0.104-4.094)
C - 1 (reference) - 1 (reference)
T 0.444 0.387 (0.073–2.046) 1 0.659 (0.108-4.041)
IL 18-137 G/C
GG - 1 (reference) - 1 (reference)
GC+CC 0.833 0.915 (0.400–2.092) 0.189 1.786 (0.749–4.262)
G - 1 (reference) - 1 (reference)
C 0.864 1.061 (0.541–2.078) 0.098 1.857 (0.887–3.889)
IL 18-607 C/A
CC - 1 (reference) - 1 (reference)
CA+AA 0.815 0.896 (0.357–2.246) 0.374 1.488 (0619–3.579)
C - 1 (reference) - 1 (reference)
A 0.882 0.957 (0.534–1.715) 0.365 1.316 (0.727–2.382)
T2DM: Type 2 diabetes mellitus, TB: Tuberculosis, OR: Odds ratio, CI: Confidence interval.
In the IL18-607 C/A, wild type CC genotype was 
found the most in the T2DM group (control vs. T2DM vs. 
T2DM-TB = 26.1% vs. 37.0% vs. 28.3%), whereas CA 
genotype was found the most in the control group (control 
vs. T2DM vs. T2DM-TB = 60.9% vs. 54.3% vs. 58.7%) 
and AA genotype was found the most in the control 
Table 1: Primer, PCR conditions, and restriction enzyme of 
cytokine genes
Polymorphism Primers and PCR conditions Restriction enzyme
IL1β+3954 C/T (F) 5’-GTT GTC ATC AGA CTT TGA CC-3’
(R) 5’-TTC AGT TCA TAT GGA CCA GA-3’
(Macro gene, USA)
95°C 4 min., 30× (95°C 30 s; 59°C 30 s; 
72°C 30 s), 72°C 4 min
Taq I (65 °C, 45 min) 
(Time-Saver Qualified 
enzyme. New England 
Biolabs, USA)
IL 18-137 G/C (R): 5’-AGG AGG GCA AAATGC ACT 
GG-3’ 
(F1): 5’-CCC CAA CTT TTA CGG AAG 
AAA AG-3’ 
(F2): 5’-CCC CAA CTT TTA CGG AAG 
AAA AC-3’ 
(CTRL): 5’-CCA ATA GGA CTG ATT ATT 
CCG CA-3’
(Macrogen, USA)
94°C 3 min., 40× (94°C 20 s; 54°C 20 s; 
72°C 20 s), 72°C 5 min
-
IL 18-607 C/A (F1): 5’-GTT GCA GAA AGT GTA AAA ATT 
ATT AC-3’
(F2): 5’-GTT GCA GAA AGT GTA AAA ATT 
ATT AA-3’
(R): 5’-TAA CCT CAT TCA GGA CTT CC-3’
CTRL): 5’-CTT TGC TAT CAT TCC AGG 
AA-3’
(Macrogen, USA)
94°C 3 min., 40× (94°C 20 s; 50°C 20 s; 
72°C 20 s), 72°C 5 min
-
PCR: Polymerase chain reaction.
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and T2DM-TB group (control vs. T2DM vs. T2DM-TB = 
13.0% vs. 8.7% vs. 13.0%). C allele of the IL18-607 C/A 
gene was found the most in T2DM group than the other 
groups, while A allele of IL18-607 C/A gene was found 
the most in control group than the others groups. The 
frequency distribution of genotype cytokines in all groups 
was in an agreement under the HWE law (p > 0.05).
Table 5 showed that genotype (CT+TT vs. CC) 
and allele (T vs. A) of IL1β+3954 C/T were no difference 
in T2DM-TB group compared to control group (p = 
0.434; OR = 0.373; 95% CI = 0.068–2.028 and p = 
0.444; OR = 0.387; 95% CI = 0.073–2.046) and no 
difference in T2DM-TB group compared to T2DM group 
(p = 1; OR = 0.652; 95% CI = 0.104–4.094 and p = 1; 
OR = 0.659; 95% CI = 0.108–4.041).
The IL18-137 G/C genotype (GC+CC vs. 
GG) and allele (C vs. G) were also no difference 
in T2DM-TB group compared to control group 
(p = 0.833; OR = 0.915; 95% CI = 0.400–2.092 and 
p = 0.864; OR = 1.061; 95% CI = 0.541–2.078) and no 
difference in T2DM-TB group compared to T2DM group 
(p = 0.189; OR = 1.786; 95% CI = 0.749–4.262 and 
p = 0.098; OR = 1.857; 95% CI = 0.887–3.889).
In this study also found that the IL 18-607 C/A 
genotype (CA+AA vs. CC) and allele (A vs. C) were 
no difference in T2DM-TB group compared to control 
group (p = 0.815; OR = 0.896; 95% CI = 0.357–2.246 
and p = 0.882; OR = 0.957; 95% CI = 0.534–1.715) and 
no difference in T2DM-TB group compared to T2DM 
group (p = 0.374; OR = 1.488; 95% CI = 0619–3.579 
and p = 0.365; OR = 1.316; 95% CI = 0.727–2.382).
Discussion
In this study, genotyping of cytokine, that is, 
IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A in 
T2DM-TB, T2DM, and control group study has been 
carried out. The results of the Chi-square goodness-
of-fit test analysis which examined the distribution of 
genotype frequencies of all groups were in accordance 
with the HWE law (p > 0.05). HWE law states that, in 
a population, the genotype and allele frequencies are 
constant from generation to generation. Many factors 
that can change the frequency of genotype and allele 
in a population are non-random mating, mutation, 
migration, genetic drift, and natural selection [17]. 
Medan city is the third-largest city in Indonesia, with 
a large population of various ethnicities. As a result, 
mating between individuals happens randomly and 
caused the distribution of the genotype of cytokines 
studied were in accordance with the HWE law.
In this current study showed that no association 
between genotypes and alleles of IL1β+3954 C/T, IL18-
137 G/C, and IL18-607 C/A gene polymorphism with 
T2DM-TB compared to control group and T2DM-TB 
compared to T2DM group. The association of 
IL1β+3954 C/T gene polymorphism with TB and latent 
TB has been reported in the literature before, with a 
different result [9], [18], [19], [20], but the associations 
of IL1β+3954 C/T gene polymorphism with T2DM-TB 
have not reported.
Several studies regarding the IL18-137 G/C 
and IL18-607 C/A gene polymorphism in T2DM-TB 
have been reported, and only the IL18-607 C/A gene 
polymorphism that has an associated T2DM-TB. The 
IL18-137 G/C gene polymorphism is not associated with 
T2DM-TB [10]. Several previous studies regarding the 
IL-18 cytokine gene polymorphism in T2DM have shown 
an association of IL18-607 C/A gene with 2 h post-loading 
plasma glucose levels in type 2 diabetes and IL18-
137 G/C gene polymorphism has a risk of T2DM with 
nephropathy [6], [7]. However, the results of this study are 
not consistent with another study [21]. A previous study by 
Han et al. (2010) showed an association between IL18-
607 C/A gene polymorphism with TB [8], but different 
result in a study by Zhou and Sheng (2019) showed 
there is no association between IL-18 polymorphisms 
(−137C/G and −607A/C) with TB [22].
Cytokines are a number of substances 
secreted by certain cells of the immune system. The 
cytokines based on the main producing cell type, 
divided into monokines and lymphokines. These cells 
will produce types of cytokines such as IL-1β, IL-6, 
IL-8, IL-12, and TNF-α, and IL-2, IFN-γ, IL-4, IL-5, 
IL-6, and IL-10. Cytokines are synthesized based on 
the nucleotide sequence in the gene. SNPs in cytokine 
genes may change the recognition sites of transcription 
factors, activation of transcriptions, and changes in 
cytokine production levels. Levels of cytokines have an 
important role in the body’s immune responses. SNIPs 
of cytokine genes also cause differences in individuals’ 
immune responses [5], [23], [24], [25].
The differences in individuals’ immune 
responses are thought to underlie the pathogenesis 
of T2DM-TB disease. Individuals’ immune responses, 
apart from being influenced by genetics, are also 
influenced by environmental factors [26], [27]. The 
results of other investigators suggest a risk of latent TB 
activation in T2DM patients who are not a primary TB 
infection [19].
Further research needs to be done to assess 
the relationship with levels and polymorphism of the 
cytokine genes as the risk factors for the occurrence 
of T2DM-TB from T2DM conditions or from control 
subjects. It is also necessary to analyze the 
environmental factors, history of previous infectious 
disease, and history of using TB drugs in future studies. 
A larger number of samples and widespread population 
are expected in subsequent studies to analyze the 
relationship of cytokine genes polymorphisms with the 
incidence of T2DM-TB.
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Conclusion
This study showed that cytokine gene 
polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and 
IL18-607 C/A) have not shown any association with 
T2DM-TB compared to control and T2DM groups, and 
all cytokine genes polymorphisms not as the risk factor 
to T2DM-TB development in this population.
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